Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash-to-Debt No Debt
ALGN's Cash-to-Debt is ranked higher than
99% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. ALGN: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
ALGN' s Cash-to-Debt Range Over the Past 10 Years
Min: 5.57  Med: No Debt Max: No Debt
Current: No Debt
Equity-to-Asset 0.72
ALGN's Equity-to-Asset is ranked higher than
66% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. ALGN: 0.72 )
Ranked among companies with meaningful Equity-to-Asset only.
ALGN' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.55  Med: 0.76 Max: 0.89
Current: 0.72
0.55
0.89
Interest Coverage 602.48
ALGN's Interest Coverage is ranked higher than
60% of the 222 Companies
in the Global Medical Devices industry.

( Industry Median: 86.37 vs. ALGN: 602.48 )
Ranked among companies with meaningful Interest Coverage only.
ALGN' s Interest Coverage Range Over the Past 10 Years
Min: 98.99  Med: No Debt Max: No Debt
Current: 602.48
Piotroski F-Score: 7
Altman Z-Score: 18.10
Beneish M-Score: -2.25
WACC vs ROIC
11.23%
59.15%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 22.34
ALGN's Operating Margin % is ranked higher than
93% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. ALGN: 22.34 )
Ranked among companies with meaningful Operating Margin % only.
ALGN' s Operating Margin % Range Over the Past 10 Years
Min: -10.89  Med: 17.06 Max: 26.54
Current: 22.34
-10.89
26.54
Net Margin % 18.98
ALGN's Net Margin % is ranked higher than
90% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.55 vs. ALGN: 18.98 )
Ranked among companies with meaningful Net Margin % only.
ALGN' s Net Margin % Range Over the Past 10 Years
Min: -10.01  Med: 15.47 Max: 26.31
Current: 18.98
-10.01
26.31
ROE % 22.70
ALGN's ROE % is ranked higher than
90% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 1.31 vs. ALGN: 22.70 )
Ranked among companies with meaningful ROE % only.
ALGN' s ROE % Range Over the Past 10 Years
Min: -12.72  Med: 19.29 Max: 42.13
Current: 22.7
-12.72
42.13
ROA % 16.38
ALGN's ROA % is ranked higher than
93% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 0.06 vs. ALGN: 16.38 )
Ranked among companies with meaningful ROA % only.
ALGN' s ROA % Range Over the Past 10 Years
Min: -9.86  Med: 14.14 Max: 31.86
Current: 16.38
-9.86
31.86
ROC (Joel Greenblatt) % 143.52
ALGN's ROC (Joel Greenblatt) % is ranked higher than
97% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 4.26 vs. ALGN: 143.52 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
ALGN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -114.37  Med: 151.29 Max: 369.18
Current: 143.52
-114.37
369.18
3-Year Revenue Growth Rate 18.40
ALGN's 3-Year Revenue Growth Rate is ranked higher than
86% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. ALGN: 18.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ALGN' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 7.6  Med: 15.4 Max: 146.7
Current: 18.4
7.6
146.7
3-Year EBITDA Growth Rate 35.60
ALGN's 3-Year EBITDA Growth Rate is ranked higher than
85% of the 208 Companies
in the Global Medical Devices industry.

( Industry Median: 5.10 vs. ALGN: 35.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
ALGN' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -35.3  Med: 25.45 Max: 45.2
Current: 35.6
-35.3
45.2
3-Year EPS without NRI Growth Rate 44.00
ALGN's 3-Year EPS without NRI Growth Rate is ranked higher than
85% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. ALGN: 44.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ALGN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -76.1  Med: 20.1 Max: 289.3
Current: 44
-76.1
289.3
GuruFocus has detected 2 Warning Signs with Align Technology Inc $ALGN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ALGN's 30-Y Financials

Financials (Next Earnings Date: 2017-07-27 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

ALGN Guru Trades in Q2 2016

Joel Greenblatt 15,104 sh (New)
Paul Tudor Jones 5,745 sh (New)
Steven Cohen 50,600 sh (+184.27%)
Jim Simons 839,200 sh (+19.75%)
RS Investment Management 601,734 sh (+5.72%)
Ken Fisher 116,266 sh (+2.36%)
Mario Gabelli 5,000 sh (unchged)
John Hussman 43,000 sh (unchged)
Ron Baron 26,640 sh (-3.13%)
Pioneer Investments 318,435 sh (-5.40%)
Ruane Cunniff 48,123 sh (-11.59%)
Columbia Wanger 2,393,012 sh (-22.19%)
Mariko Gordon 42,420 sh (-27.34%)
» More
Q3 2016

ALGN Guru Trades in Q3 2016

Steve Mandel 2,436,920 sh (New)
George Soros 2,515 sh (New)
Jim Simons 944,200 sh (+12.51%)
Ruane Cunniff 48,123 sh (unchged)
Ron Baron 26,640 sh (unchged)
John Hussman Sold Out
Paul Tudor Jones 5,700 sh (-0.78%)
Ken Fisher 109,455 sh (-5.86%)
Pioneer Investments 278,266 sh (-12.61%)
Mario Gabelli 4,000 sh (-20.00%)
Mariko Gordon 30,286 sh (-28.60%)
Columbia Wanger 1,614,224 sh (-32.54%)
Steven Cohen 25,300 sh (-50.00%)
Joel Greenblatt 2,504 sh (-83.42%)
» More
Q4 2016

ALGN Guru Trades in Q4 2016

John Hussman 50,000 sh (New)
Jim Simons 1,316,500 sh (+39.43%)
Mariko Gordon 32,066 sh (+5.88%)
Pioneer Investments 285,369 sh (+2.55%)
Steve Mandel 2,476,534 sh (+1.63%)
Ron Baron 26,640 sh (unchged)
George Soros Sold Out
Paul Tudor Jones Sold Out
Joel Greenblatt Sold Out
Ruane Cunniff 48,118 sh (-0.01%)
Ken Fisher 102,242 sh (-6.59%)
Columbia Wanger 1,400,451 sh (-13.24%)
Mario Gabelli 2,500 sh (-37.50%)
Steven Cohen 8,000 sh (-68.38%)
» More
Q1 2017

ALGN Guru Trades in Q1 2017

Jim Simons 1,426,800 sh (+8.38%)
John Hussman 50,000 sh (unchged)
Steve Mandel 2,476,534 sh (unchged)
Mariko Gordon 32,066 sh (unchged)
Steven Cohen Sold Out
Ruane Cunniff 47,593 sh (-1.09%)
Ron Baron 26,040 sh (-2.25%)
Ken Fisher 98,065 sh (-4.09%)
Pioneer Investments 239,434 sh (-16.10%)
Columbia Wanger 1,146,288 sh (-18.15%)
Mario Gabelli 2,000 sh (-20.00%)
» More
» Details

Insider Trades

Latest Guru Trades with ALGN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339113    SIC: 3842
Compare:OTCPK:SONVY, NYSE:TFX, NYSE:VAR, OTCPK:CNVVY, OTCPK:SNNUF, OTCPK:WILLF, OTCPK:CHEOY, NAS:ABMD, NAS:MASI, OTCPK:GGNDF, OTCPK:FSPKF, OTCPK:EKTAY, NAS:NUVA, NAS:IART, OTCPK:SHWGY, NYSE:GMED, OTCPK:AMBFF, NAS:WMGI, NAS:LIVN, NYSE:PEN » details
Traded in other countries:AFW.Germany,
Headquarter Location:USA
Align Technology Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM digital services used in dentistry, orthodontics, and dental records storage. Its segments are Clear Aligner and Scanners & Services.

Align Technology Inc was incorporated in Delaware in April 1997. The Company designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The Company has two operating segments: Clear Aligner and Scanners and Services. The Clear Aligner segment consists of its Invisalign System which includes Invisalign Full, Express/Lite, Teen, Assist, Vivera Retainers, along with its training and ancillary products for treating malocclusion. The Scanners and Services segment consists of intra-oral scanning systems, and additional services available with the intra-oral scanners, that provide digital alternatives to the traditional cast models. This segment includes its iTero scanner and OrthoCAD services. The Company is subject to various laws inside and outside the U.S. concerning its relationships with healthcare professionals and government officials, price reporting and regulation, the promotion, sales and marketing of its products and services, the importation and exportation of its products, the operation of its facilities and distribution of its products. It is also subject to varying degrees of government regulation in the various countries in which the Company do business.

Top Ranked Articles about Align Technology Inc

Align Technology to Announce Second Quarter 2016 Results on July 28, 2016
SAN JOSE, CA--(Marketwired - July 01, 2016) - Align Technology, Inc. (NASDAQ: ALGN) announced today that the Company will report second quarter 2016 financial results on Thursday, July 28, 2016 after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Company's website at http://investor.aligntech.com.Following the press release, the Company will host a conference call to discuss its financial results. The conference call will begin at 4:30 p.m. ET (1:30 p.m. PT) and will also be available as an audio web cast live via the Internet. To access the web cast, please visit http://investor.aligntech.com. To access the conference call, please dial 201-689-8261 approximately fifteen minutes prior to the start of the call.An archived audio web cast will be available beginning approximately one hour after the call's conclusion and will remain available for approximately 12 months. Additionally, a telephonic replay of the call can be accessed by dialing 877-660-6853 with conference number 13640324 followed by #. The replay must be accessed from international locations by dialing 201-612-7415 and using the same account and conference numbers referenced above. The telephonic replay will be available through 5:30 p.m. ET on August 11, 2016.About Align Technology, Inc.Align Technology is the leader in modern clear aligner orthodontics that designs, manufactures and markets the Invisalign® system, which provides dental professionals with a range of treatment options for adults and teenagers. The Company also offers the iTero 3D digital scanning system and services for orthodontic and restorative dentistry. Align Technology was founded in March 1997 and received FDA clearance to market the Invisalign system in 1998. Visit www.aligntech.com for more information.For additional information about the Invisalign system or to find an Invisalign provider in your area, please visit www.invisalign.com. For additional information about iTero 3D digital scanning system, please visit www.itero.com.
Investor Relations Contact
Yin Cantor
Align Technology, Inc.
(408) 470-1150
Email contact

Press Contact
Shannon Mangum Henderson
Ethos Communication, Inc.
(678) 261-7803
Email contact




Read more...
Align Technology to Speak at Upcoming Financial Conferences
SAN JOSE, CA--(Marketwired - June 06, 2016) - Align Technology, Inc. (NASDAQ: ALGN) today announced that the company is scheduled to participate in upcoming financial conferences. The presentations, as noted below, will be webcast live via the Investor Relations section of Align Technology's website at http://investor.aligntech.com. An archived replay will remain on the web site for approximately three months.Conference: Jefferies Healthcare Conference, New York, New York
Date: Wednesday, June 8, 2016
Presentation: 1:30 p.m. to 1:55 p.m. Eastern Time
Speaker: David White, CFOConference: Goldman Sachs 37th Annual Global Healthcare Conference, Rancho Palos Verdes, California
Date: Thursday, June 9, 2016
Presentation: 8:00 a.m. to 8:35 a.m. Pacific Time
Speaker: Joseph Hogan, President and CEOAbout Align Technology, Inc.
Align Technology is the leader in modern clear aligner orthodontics that designs, manufactures and markets the Invisalign® system, which provides dental professionals with a range of treatment options for adults and teenagers. The Company also offers the iTero 3D digital scanning system and services for orthodontic and restorative dentistry. Align Technology was founded in March 1997 and received FDA clearance to market the Invisalign system in 1998. Visit www.aligntech.com for more information.For additional information about the Invisalign system or to find an Invisalign provider in your area, please visit www.invisalign.com. For additional information about iTero 3D digital scanning system, please visit www.itero.com.


Read more...
Align Technology Awards Fourteen Grants Totaling $310,000 as Part of Its University Research Award Program 2016 for Orthodontic Therapy and Intraoral Scanners
SAN JOSE, CA--(Marketwired - June 01, 2016) - Align Technology, Inc. (NASDAQ: ALGN) today announced fourteen research awards totaling $310,000 in new funding to four universities in North America and eight International universities for projects seeking to better understand treatment in orthodontics, dentistry and the uses of intraoral scanners. "We are very excited that universities all over the globe are showing great interest in the Align Research Awards Program," said John Morton, Align Technology Sr. Technical Fellow. "The number of applications and the quality of the proposed research increases every year. Align is honored to be able to provide this opportunity for researchers who endeavor to improve dental and orthodontic treatment of patients worldwide."The North America research award recipients for 2016 are:
Dr. Katie Julien and Dr. James Boley at Texas A&M University Baylor College of Dentistry (Dallas, TX), $25,000 Dr. J. Martin Palomo and Sofia Xofylli at Case Western Reserve University (Cleveland, OH), $25,000 Dr. Prashanti Bollu and Dr. Glen Roberson at Roseman University of Health Sciences (Henderson, NV), $25,000 Dr. Tarek El-Bialy at University of Alberta (Alberta, CA), $25,000 The International research award recipients for 2016 are:
Dr. Guo Hua Tang, Dr. Feng Ting Chu and Dr. Yi Ming Yang at Shanghai JiaoTong University (Shanghai, China), $25,000 Dr. Jing Guo, Dr. Deshui, Dr. Xiaoxin Shi, Dr. Delong Jiao, Dr. Shanshan Cao, Dr. Jing Liu, Dr. Guangxue Wu, Dr. Dingyang Li, Dr. Ning Zhou, Dr. Xinwei Chen and Dr. Jiayu Li at Shandong University (Shandong, China), $25,000 Dr. Ellen Wen-Ching Ko at Chang Gung University (Taipei, Taiwan), $25,000 Dr. Kamy Malekian, Dr. Juan Carlos Palma Fernandez, Dr. Leonor Muelas Fernandez and Dr. Eva Maria Rosa Vazquez at Universidad Complutense de Madrid (Madrid, Spain), $25,000 Dr. Christina Erbe and Dr. Thomas Drechsler at University Medical Center of the Johannes Gutenberg (Mainz, Germany), $25,000 Dr. Laura Strohmenger, Dr. Angela Malerba and Dr. Araxi Balian at Universita degli Studi di Milano (Milano, Italy), $25,000 Dr. Graciela Julia Barreda, Dr. Gabriela Caldentey, Dr. Elizabeth Alejandra Dzierewianko, Dr. Valeria Mazza, Dr. Rocio Moreno, Dr. Karina Andrea Munoz, Dr. Gisela Ines Piccoli and Dr. Hugo Jorge Romanelli at S.A.O.-U.C.E.S (Buenos Aires, Argentina), $25,000 Dr. Chiu-Mei Lo and Dr. Susie Lin at National Defense Medical Center (Taipei, Taiwan), $25,000 "The response from the academic community has been increasingly positive in the European and Asia Pacific regions, especially Greater China, where there has been increase in growth of clear aligner therapy and keen interest in advancing the science and research at these reputable universities," said Mitra Derakhshan, Align Technology Sr. Director, Global Clinical.The funded research studies cover a wide range of topics including root resorption, treatment stability, comparisons of success of treatment using aligners versus fixed appliances, and the use of aligners in surgical treatment.The intraoral scanner research award recipients for 2016 are:
Dr. Sarah Rolland and Mrs. Ania Cala at Newcastle University (Newcastle, UK), $5,000 Dr. Giuseppe Riccardo Spampinato and Tommaso Castroflorio at Universita degli Studi di Catania (Catania, Italy), $5,000 The intraoral scanner awards address the use of scanners in education and in the treatment of special needs patients. All proposals received were reviewed and prioritized by an independent academic committee in a blind evaluation. The 2017 Align Research Award Program submission details are to be announced later this year.
About Align Technology, Inc.

Align Technology is the leader in modern clear aligner orthodontics that designs, manufactures and markets the Invisalign® system, which provides dental professionals with a range of treatment options for adults and teenagers. Align also offers the iTero 3D digital scanning system and services for orthodontic and restorative dentistry. Align was founded in March 1997 and received FDA clearance to market the Invisalign system in 1998. Visit www.aligntech.com for more information.For additional information about the Invisalign system or to find an Invisalign provider in your area, please visit www.invisalign.com. For additional information about the iTero 3D digital scanning system, please visit www.itero.com.


Read more...

Ratios

vs
industry
vs
history
PE Ratio 52.57
ALGN's PE Ratio is ranked lower than
74% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 27.53 vs. ALGN: 52.57 )
Ranked among companies with meaningful PE Ratio only.
ALGN' s PE Ratio Range Over the Past 10 Years
Min: 5.57  Med: 32.52 Max: 222.88
Current: 52.57
5.57
222.88
Forward PE Ratio 43.67
ALGN's Forward PE Ratio is ranked lower than
83% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 21.79 vs. ALGN: 43.67 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 52.57
ALGN's PE Ratio without NRI is ranked lower than
73% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 27.51 vs. ALGN: 52.57 )
Ranked among companies with meaningful PE Ratio without NRI only.
ALGN' s PE Ratio without NRI Range Over the Past 10 Years
Min: 5.57  Med: 32.52 Max: 222.88
Current: 52.57
5.57
222.88
Price-to-Owner-Earnings 76.73
ALGN's Price-to-Owner-Earnings is ranked lower than
78% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 32.96 vs. ALGN: 76.73 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
ALGN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.35  Med: 31.22 Max: 895
Current: 76.73
5.35
895
PB Ratio 11.02
ALGN's PB Ratio is ranked lower than
87% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. ALGN: 11.02 )
Ranked among companies with meaningful PB Ratio only.
ALGN' s PB Ratio Range Over the Past 10 Years
Min: 1.86  Med: 5.37 Max: 15.87
Current: 11.02
1.86
15.87
PS Ratio 9.99
ALGN's PS Ratio is ranked lower than
82% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. ALGN: 9.99 )
Ranked among companies with meaningful PS Ratio only.
ALGN' s PS Ratio Range Over the Past 10 Years
Min: 1.31  Med: 4.67 Max: 9.99
Current: 9.99
1.31
9.99
Price-to-Free-Cash-Flow 74.35
ALGN's Price-to-Free-Cash-Flow is ranked lower than
78% of the 112 Companies
in the Global Medical Devices industry.

( Industry Median: 27.61 vs. ALGN: 74.35 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
ALGN' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 11.18  Med: 23.45 Max: 28460
Current: 74.35
11.18
28460
Price-to-Operating-Cash-Flow 43.51
ALGN's Price-to-Operating-Cash-Flow is ranked lower than
79% of the 140 Companies
in the Global Medical Devices industry.

( Industry Median: 20.26 vs. ALGN: 43.51 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ALGN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.24  Med: 19.89 Max: 351.69
Current: 43.51
8.24
351.69
EV-to-EBIT 42.04
ALGN's EV-to-EBIT is ranked lower than
70% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 24.54 vs. ALGN: 42.04 )
Ranked among companies with meaningful EV-to-EBIT only.
ALGN' s EV-to-EBIT Range Over the Past 10 Years
Min: -378.4  Med: 22 Max: 157.9
Current: 42.04
-378.4
157.9
EV-to-EBITDA 38.03
ALGN's EV-to-EBITDA is ranked lower than
78% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 19.31 vs. ALGN: 38.03 )
Ranked among companies with meaningful EV-to-EBITDA only.
ALGN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -248.4  Med: 19.6 Max: 578.7
Current: 38.03
-248.4
578.7
PEG Ratio 2.20
ALGN's PEG Ratio is ranked higher than
58% of the 83 Companies
in the Global Medical Devices industry.

( Industry Median: 2.52 vs. ALGN: 2.20 )
Ranked among companies with meaningful PEG Ratio only.
ALGN' s PEG Ratio Range Over the Past 10 Years
Min: 1.22  Med: 1.68 Max: 2.72
Current: 2.2
1.22
2.72
Shiller PE Ratio 117.30
ALGN's Shiller PE Ratio is ranked lower than
84% of the 50 Companies
in the Global Medical Devices industry.

( Industry Median: 49.41 vs. ALGN: 117.30 )
Ranked among companies with meaningful Shiller PE Ratio only.
ALGN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 73.35  Med: 96.32 Max: 680.5
Current: 117.3
73.35
680.5
Current Ratio 2.51
ALGN's Current Ratio is ranked higher than
55% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. ALGN: 2.51 )
Ranked among companies with meaningful Current Ratio only.
ALGN' s Current Ratio Range Over the Past 10 Years
Min: 1.59  Med: 2.95 Max: 6.96
Current: 2.51
1.59
6.96
Quick Ratio 2.42
ALGN's Quick Ratio is ranked higher than
66% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. ALGN: 2.42 )
Ranked among companies with meaningful Quick Ratio only.
ALGN' s Quick Ratio Range Over the Past 10 Years
Min: 1.55  Med: 2.89 Max: 6.82
Current: 2.42
1.55
6.82
Days Inventory 34.85
ALGN's Days Inventory is ranked higher than
91% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 130.04 vs. ALGN: 34.85 )
Ranked among companies with meaningful Days Inventory only.
ALGN' s Days Inventory Range Over the Past 10 Years
Min: 9.28  Med: 24.09 Max: 34.85
Current: 34.85
9.28
34.85
Days Sales Outstanding 84.67
ALGN's Days Sales Outstanding is ranked lower than
65% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 68.94 vs. ALGN: 84.67 )
Ranked among companies with meaningful Days Sales Outstanding only.
ALGN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 57.57  Med: 63.3 Max: 84.67
Current: 84.67
57.57
84.67
Days Payable 48.06
ALGN's Days Payable is ranked lower than
70% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. ALGN: 48.06 )
Ranked among companies with meaningful Days Payable only.
ALGN' s Days Payable Range Over the Past 10 Years
Min: 25.83  Med: 46.94 Max: 68.75
Current: 48.06
25.83
68.75

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 0.40
ALGN's 3-Year Average Share Buyback Ratio is ranked higher than
87% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. ALGN: 0.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ALGN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -139.2  Med: -3.4 Max: 0.5
Current: 0.4
-139.2
0.5

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 87.82
ALGN's Price-to-Net-Cash is ranked lower than
77% of the 103 Companies
in the Global Medical Devices industry.

( Industry Median: 17.13 vs. ALGN: 87.82 )
Ranked among companies with meaningful Price-to-Net-Cash only.
ALGN' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 0  Med: 20.76 Max: 417
Current: 87.82
0
417
Price-to-Net-Current-Asset-Value 22.88
ALGN's Price-to-Net-Current-Asset-Value is ranked lower than
76% of the 206 Companies
in the Global Medical Devices industry.

( Industry Median: 6.88 vs. ALGN: 22.88 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
ALGN' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0  Med: 9.07 Max: 25.8
Current: 22.88
0
25.8
Price-to-Tangible-Book 12.11
ALGN's Price-to-Tangible-Book is ranked lower than
78% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 4.11 vs. ALGN: 12.11 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
ALGN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.91  Med: 6.11 Max: 16.46
Current: 12.11
0.91
16.46
Price-to-Intrinsic-Value-Projected-FCF 3.87
ALGN's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
66% of the 129 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. ALGN: 3.87 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ALGN' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0  Med: 2.2 Max: 14.5
Current: 3.87
0
14.5
Price-to-Median-PS-Value 2.14
ALGN's Price-to-Median-PS-Value is ranked lower than
87% of the 242 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. ALGN: 2.14 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ALGN' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0  Med: 0.93 Max: 6.78
Current: 2.14
0
6.78
Price-to-Peter-Lynch-Fair-Value 2.10
ALGN's Price-to-Peter-Lynch-Fair-Value is ranked lower than
58% of the 57 Companies
in the Global Medical Devices industry.

( Industry Median: 1.61 vs. ALGN: 2.10 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
ALGN' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0  Med: 1.94 Max: 14.72
Current: 2.1
0
14.72
Price-to-Graham-Number 5.32
ALGN's Price-to-Graham-Number is ranked lower than
78% of the 138 Companies
in the Global Medical Devices industry.

( Industry Median: 2.19 vs. ALGN: 5.32 )
Ranked among companies with meaningful Price-to-Graham-Number only.
ALGN' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0  Med: 3.1 Max: 17.76
Current: 5.32
0
17.76
Earnings Yield (Greenblatt) % 2.37
ALGN's Earnings Yield (Greenblatt) % is ranked higher than
58% of the 432 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. ALGN: 2.37 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ALGN' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.6  Med: 4.2 Max: 9.7
Current: 2.37
0.6
9.7
Forward Rate of Return (Yacktman) % 33.14
ALGN's Forward Rate of Return (Yacktman) % is ranked higher than
92% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 8.85 vs. ALGN: 33.14 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
ALGN' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -5.8  Med: 2.7 Max: 33.5
Current: 33.14
-5.8
33.5

More Statistics

Revenue (TTM) (Mil) $1,151
EPS (TTM) $ 2.69
Beta1.50
Short Percentage of Float5.87%
52-Week Range $77.07 - 145.24
Shares Outstanding (Mil)80.33

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 1,349 1,593
EPS ($) 3.17 3.89
EPS without NRI ($) 3.17 3.89
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for ALGN

Headlines

Articles On GuruFocus.com
Align Technology Launches Invisalign Brand Marketing Campaign to Challenge Metal Braces as the Statu May 09 2017 
Stocks That Are Beating the Market Apr 12 2017 
6 Stocks That Are Beating the Market Oct 11 2016 
Align Technology to Announce Second Quarter 2016 Results on July 28, 2016 Jul 01 2016 
Align Technology to Speak at Upcoming Financial Conferences Jun 06 2016 
Align Technology Awards Fourteen Grants Totaling $310,000 as Part of Its University Research Award P Jun 01 2016 
Align Technology to Host Analyst Meeting on June 2, 2016 May 16 2016 
Stuart Hockridge Joins Align Technology as Vice President of Global Human Resources May 09 2016 
Align Technology Announces $50 Million Accelerated Stock Repurchase Program and a 10b5-1 Stock Repur May 04 2016 
Align Technology and 3Shape Announce New Workflow Integration Including Trios Scanner Interoperabili Apr 28 2016 

More From Other Websites
Align Technology Rises with Invisalign, SmartTrack Patents May 25 2017
Align Technology to Speak at Upcoming Financial Conferences May 25 2017
Align Technology Receives U.S. Patents for SmartTrack(R) Invisalign(R) Aligner Material May 24 2017
CORRECTION - Align Technology Reaches 1 Million Invisalign Teenagers May 24 2017
Align Technology Reaches 1 Million Invisalign Teenagers May 24 2017
Quest Diagnostics Poised on Solid Q1 Results Despite Woes May 22 2017
Medtronic (MDT) RESOLUTE ONYX Meets Primary Study Endpoint May 19 2017
Small Fund Scores Big Betting on Chinese Stocks and This Is Why You Should Follow It May 17 2017
Edwards Lifesciences SAPIEN 3 Heart Valve Data Positive May 17 2017
Why Align Technology (ALGN) Could Be an Impressive Growth Stock May 11 2017
Align Technology Global Funding Awarded Towards Advancing Orthodontic and Dental Research May 10 2017
Top Stock Picks for the Week of May 8th May 09 2017
Align Technology Is My Biggest Stock Winner, and I'm Not Selling May 09 2017
Align Technology Launches Invisalign Brand Marketing Campaign to Challenge Metal Braces as the... May 09 2017
What I'm Learning From My Best And Worst Stock Picks May 08 2017
Align Technology Invisalign Sales Strong, Currency Woes Stay May 08 2017
Align Technology, Community Health Systems, Ultra Clean Holdings, Tyson Foods and Huntsman... May 08 2017
Bull of the Day: Align Technology (ALGN) May 08 2017
Zacks Investment Ideas feature highlights: Regeneron, Edwards Lifesciences, Alexion Pharmaceuticals,... May 05 2017
Align Technology (ALGN) Rises: Stock Adds 7.5% in Session May 05 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)